Ventricular Fibrillation due to Automated Atrial Threshold Testing in a Patient with an Implantable Cardioverter Defibrillator

被引：1
|
作者：
Schellevis, Mindel M. [1 ,2 ]
Van Halm, Vokko P. [2 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Div Cardiol, NL-1007 HV Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Div Cardiol, NL-1105 AZ Amsterdam, Netherlands
来源：
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2015年 / 38卷 / 11期
关键词：
threshold test; implantable cardioverter defibrillator; ventricular fibrillation; channelopathy; DDI mode; CAPTURE MANAGEMENT; PACEMAKER LONGEVITY; ALGORITHMS; VERIFICATION; STIMULATION;
D O I：
10.1111/pace.12639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1355 / 1358
页数：4
相关论文
共 50 条
  • [1] Influence of drive cycle length ventricular fibrillation during on initiation of implantable cardioverter defibrillator threshold testing
    Sanghvi, Neil K.
    Lelorier, Paul
    Gururaj, Arjun V.
    Monahan, Kevin M.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (09): : 926 - 929
  • [2] Failure to detect ventricular fibrillation in a patient with an implantable cardioverter-defibrillator
    Antolinos-Perez, Maria J.
    Garcia-Alberola, Arcadio
    Valdes-Chavarri, Mariano
    REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (05): : 517 - 518
  • [3] Impact of atrial fibrillation in an implantable cardioverter defibrillator cohort
    Kraaier, K.
    Van Rennes, B.
    Velthuis, B. Oude
    Dorman, H. G. R.
    Stevenhagen, Y. J.
    Van Opstal, J.
    Scholten, M. F.
    EUROPEAN HEART JOURNAL, 2013, 34 : 266 - 266
  • [4] Radiotherapy in patient with an automated implantable cardioverter defibrillator
    Allouche, E.
    Oumaya, Z.
    Abidi, R.
    JOURNAL OF RADIOTHERAPY IN PRACTICE, 2022, 21 (04) : 563 - 565
  • [5] Failure to detect ventricular fibrillation in a patient with an implantable cardioverter-defibrillator [3]
    Antolinos-Pérez, María J.
    García-Alberola, Arcadio
    Redondo-Bermejo, Belén
    Valdés-Chávarri, Mariano
    Technische Uberwachung, 2006, 47 (06): : 517 - 518
  • [6] Implantable cardioverter defibrillator for alectinib induced ventricular fibrillation
    Mandal, Amit K. J.
    Stokes, Sarah A.
    Missouris, Constantinos G.
    CLINICAL TOXICOLOGY, 2020, 58 (07) : 781 - 784
  • [7] Clinical characteristics and ventricular tachyarrhythmia events in patients with an implantable cardioverter defibrillator and atrial fibrillation
    Ammar, S.
    Streitner, F.
    Schoene, N.
    Veltmann, C.
    Schimpf, R.
    Wolpert, C.
    Borggrefe, M.
    Kuschyk, J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 281 - 282
  • [8] Atrial fibrillation increases the risk of recurrent ventricular tachyarrhythmias in implantable cardioverter defibrillator recipients
    Rusnak, Jonas
    Behnes, Michael
    Reiser, Linda
    Schupp, Tobias
    Bollow, Armin
    Reichelt, Thomas
    Borggrefe, Martin
    Ellguth, Dominik
    Engelke, Niko
    El-Battrawy, Ibrahim
    Ansari, Uzair
    Barre, Max
    Weidner, Kathrin
    Mueller, Julian
    Barth, Christian
    Meininghaus, Dirk Grosse
    Akin, Muharrem
    Bertsch, Thomas
    Taton, Gabriel
    Akin, Ibrahim
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2021, 114 (6-7) : 443 - 454
  • [9] Implantable Cardioverter Defibrillator with and without Defibrillation Threshold Testing
    Codner, Pablo
    Nevzorov, Roman
    Kusniec, Jairo
    Haim, Moti
    Zabarski, Ronit
    Strasberg, Boris
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2012, 14 (06): : 343 - 346
  • [10] Impact of atrial fibrillation in patients with implantable cardioverter-defibrillator
    Madrid, A
    Rebollo, JG
    Peña, G
    Rodriguez, A
    Cano, L
    Mejia, MA
    Moro, C
    Camino, A
    EUROPEAN HEART JOURNAL, 2001, 22 : 476 - 476
12345